How many doses of Gardasil 9 (nonavalent HPV vaccine) should a 16‑year‑old who completed a two‑dose Gardasil 4 (quadrivalent HPV vaccine) series at age 12 receive?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 22, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

No Additional Doses of Gardasil 9 Are Needed

A 16-year-old who completed a two-dose Gardasil 4 series at age 12 does not require any doses of Gardasil 9 and is considered fully vaccinated.

Rationale

Since this patient initiated HPV vaccination before age 15 (at age 12) and completed a two-dose series, they meet the current definition of adequate vaccination. The two-dose schedule is considered complete and protective when started before the 15th birthday 1.

Key Considerations:

Age at Initiation Determines Dosing Schedule:

  • Vaccination initiated before age 15: 2-dose series is complete (0,6-12 months) 1
  • Vaccination initiated at age 15 or later: 3-dose series required 1

Cross-Protection from Gardasil 4:

  • Gardasil 4 provides protection against HPV types 6,11,16, and 18
  • These four types account for approximately 70% of cervical cancers and 90% of genital warts 1
  • The patient already has robust immunity to these critical oncogenic types

Gardasil 9 Supplementation Data:

  • While Gardasil 9 adds coverage for five additional high-risk types (31,33,45,52,58), the FDA label data shows that individuals previously vaccinated with Gardasil 4 who later received Gardasil 9 achieved lower antibody titers (25-63% of GMTs) compared to vaccine-naïve individuals 2
  • The clinical significance of supplemental Gardasil 9 vaccination in previously vaccinated individuals remains unknown 2, 3
  • No efficacy data exists for Gardasil 9 in preventing disease from the five additional types in those already vaccinated with Gardasil 4 2

Important Caveats

This recommendation assumes:

  • The two doses were appropriately spaced (minimum 5 months apart, ideally 6-12 months)
  • The patient was immunocompetent at the time of vaccination
  • Both doses were documented and verified

If considering supplemental Gardasil 9 (not routinely recommended):

  • This would be an off-label use without established benefit
  • Would require shared decision-making about uncertain additional protection
  • The patient would need a full 3-dose series of Gardasil 9 if pursued 2, 3

Continue routine cervical cancer screening per guidelines regardless of vaccination status, as vaccines do not protect against all oncogenic HPV types 4, 5.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.